Search Results - "Lahr, Rachel"

Refine Results
  1. 1

    Impact of margin thermal treatment after EMR of giant (≥40 mm) colorectal lateral spreading lesions by Nader, Setarah Mohammad, Lahr, Rachel E., Rex, Douglas K.

    Published in Gastrointestinal endoscopy (01-03-2023)
    “…Increasing lesion size is a risk factor for recurrence after piecemeal EMR (pEMR). Snare-tip soft coagulation (STSC) treatment of the normal-appearing margin…”
    Get full text
    Journal Article
  2. 2

    Frequency of Errors in Colorectal Lesion Description and Management Prior to Referral to A Tertiary Center by Ichkhanian, Yervant, Lahr, Rachel E., Guardiola, John J., Rex, Douglas K.

    Published in Gastrointestinal endoscopy (29-10-2024)
    “…Accurate reporting of polyp characteristics is crucial for effective resource allocation in endoscopic resection referrals. We present our experience with…”
    Get full text
    Journal Article
  3. 3

    Prevalence of synchronous neoplasia in patients with large pedunculated colorectal polyps by El Rahyel, Ahmed, Lahr, Rachel E, Rex, Douglas K

    Published in Endoscopy (01-06-2023)
    “…Large (≥ 20 mm) nonpedunculated colorectal lesions have high rates of synchronous neoplasia and advanced neoplasia. Synchronous neoplasia prevalence in…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Cold versus hot snare resection with or without submucosal injection of 6- to 15-mm colorectal polyps: a randomized controlled trial by Rex, Douglas K., Anderson, Joseph C., Pohl, Heiko, Lahr, Rachel E., Judd, Stephanie, Antaki, Fadi, Lilley, Kirthi, Castelluccio, Peter F., Vemulapalli, Krishna C.

    Published in Gastrointestinal endoscopy (01-08-2022)
    “…Cold snare resection of colorectal lesions has been found to be safe and effective for an expanding set of colorectal lesions. In this study, we sought to…”
    Get full text
    Journal Article
  6. 6

    Assessment of submucosal distortion and mass effect seen at follow-up after colorectal EMR with ORISE (with video) by Lahr, Rachel E., DeWitt, John M., Zhang, Dongwei, Rex, Douglas K.

    Published in Gastrointestinal endoscopy (01-10-2022)
    “…ORISE (Boston Scientific, Marlborough, Mass, USA) is a viscous gel used for submucosal injection. We noted anecdotally that ORISE is associated with submucosal…”
    Get full text
    Journal Article
  7. 7

    2021 Patient Perceptions Regarding Colonoscopy Experience by Vemulapalli, Krishna C., Lahr, Rachel E., Rex, Douglas K.

    Published in Journal of clinical gastroenterology (01-04-2023)
    “…We sought to document patient perceptions in 2021 regarding colonoscopy experience and potential deterrents to repeat colonoscopy. Bowel preparation has been…”
    Get full text
    Journal Article
  8. 8
  9. 9

    One-device colonoscopy: feasibility, cost savings, and plastic waste reduction by procedure indication, when performed by a high detecting colonoscopist by Rex, Douglas K, Gallagher, Jackson A, Lahr, Rachel E, Vemulapalli, Krishna C, Sharma, Prateek, Hassan, Cesare

    Published in Endoscopy (01-02-2024)
    “…Cold forceps and snares are each effective for removing polyps of 1-3 mm, while snares are more effective for polyps of 4-10 mm in size. If, in the same…”
    Get more information
    Journal Article
  10. 10

    Characterization of endoscopic features and histology of a distinct mucosal transition zone on the ileocecal valve (with video) by Rex, Douglas K., Lahr, Rachel E., Guardiola, John J., Dewitt, John M., Zhang, Dongwei

    Published in Gastrointestinal endoscopy (01-09-2023)
    “…We have endoscopically encountered a zone of transitional mucosa between the colonic and ileal mucosa located in a 3- to 10-mm-wide ring around the ileocecal…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Impact of including epinephrine in the submucosal injectate for colorectal EMR on postprocedural pain: a randomized controlled trial by Rex, Douglas K., Lahr, Rachel E., Peterson, Merritt M., Vemulapalli, Krishna C.

    Published in Gastrointestinal endoscopy (01-03-2022)
    “…EMR is first-line therapy for colorectal laterally spreading lesions. Some colonoscopists include epinephrine in the submucosal injectate, which we observed…”
    Get full text
    Journal Article
  13. 13

    Safety of first surveillance colonoscopy at 12 months after piecemeal EMR of large nonpedunculated colorectal lesions by Bobay, Michael C., Lahr, Rachel E., Shultz, Jeremiah, Vemulapalli, Krishna C., Guardiola, John J., Rex, Douglas K.

    Published in Gastrointestinal endoscopy (01-11-2024)
    “…After piecemeal EMR (pEMR) of nonpedunculated colorectal lesions ≥20 mm, guidelines recommend first endoscopic surveillance at 6 months. However, initial…”
    Get full text
    Journal Article
  14. 14

    Implications of stable or increasing adenoma detection rate on the need for continuous measurement by El Rahyel, Ahmed, Vemulapalli, Krishna C., Lahr, Rachel E., Rex, Douglas K.

    Published in Gastrointestinal endoscopy (01-05-2022)
    “…Measurement of the adenoma detection rate (ADR) is resource intensive, and the benefit of continuous measurement for colonoscopists with high ADR is unclear…”
    Get full text
    Journal Article
  15. 15

    Yield of a second right colon examination during colonoscopy after a first examination using a mucosal exposure device by Vemulapalli, Krishna C., Lahr, Rachel E., Lee, Christopher J., Abdullah, Noor, Rex, Douglas K.

    Published in Gastrointestinal endoscopy (01-01-2022)
    “…Double right colon examination during colonoscopy has been advocated to reduce the risk of interval cancer in the right colon. Whether 2 examinations are…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Impact of Expanding Screening Colonoscopy Interval on Providers Choice of Prescribing Colonoscopy for Colorectal Cancer Screening by Rex, Douglas K., Lahr, Rachel E., Handel, Daniel A., Gebke, Kevin B., Vemulapalli, Krishna C.

    Published in Journal of clinical gastroenterology (01-10-2022)
    “…We investigated if increasing the colonoscopy screening interval from 10 to 15 years would increase provider preferences for colonoscopy as a screening test…”
    Get full text
    Journal Article
  19. 19

    SIC-8000 versus hetastarch as a submucosal injection fluid for EMR: a randomized controlled trial by Rex, Douglas K., Broadley, Heather M., Garcia, Jonathan R., Lahr, Rachel E., MacPhail, Margaret E., McWhinney, Connor D., Searight, Meghan P., Sullivan, Andrew W., Mahajan, Neal, Eckert, George J., Vemulapalli, Krishna C.

    Published in Gastrointestinal endoscopy (01-11-2019)
    “…Viscous solutions provide a superior submucosal cushion for EMR. SIC-8000 (Eleview; Aries Pharmaceuticals, La Jolla, Calif) is a commercially available U.S…”
    Get full text
    Journal Article
  20. 20

    Frequency of serrated polyposis syndrome recognition by community endoscopists by McWhinney, Connor D., Lahr, Rachel E., Rex, Douglas K.

    Published in Endoscopy International Open (01-09-2023)
    “…Abstract Background and study aims Some data indicate serrated polyposis syndrome (SPS) is underdiagnosed. We determined the frequency of SPS diagnosis by…”
    Get full text
    Journal Article